Endpoints News 22. Dez. 2025 China's new commercial insurance model could broaden access to Alzheimer's drugs
Endpoints News 22. Dez. 2025 US charges six people with insider trading in case including Olema Oncology
Endpoints News 22. Dez. 2025 Windward gets bispecific from Qyuns in its second China deal of the year
Endpoints News 22. Dez. 2025 Aktis Oncology files for IPO to fund Lilly-partnered radiopharma pipeline
Endpoints News 20. Dez. 2025 Nine more MFN deals; Western drugmakers turn to China; Chai Discovery's raise; and more
Endpoints News 19. Dez. 2025 Senators point fingers over who blocked the rare disease voucher reauthorization